Pages that link to "Q37652358"
Jump to navigation
Jump to search
The following pages link to Todd Lencz (Q37652358):
Displaying 50 items.
- Implications for health and disease in the genetic signature of the Ashkenazi Jewish population (Q21184013) (← links)
- Orbital Frontal and Amygdala Volume Reductions in Obsessive-compulsive Disorder (Q22253044) (← links)
- Localisation of increased prefrontal white matter in pathological liars (Q24657340) (← links)
- COMT genetic variation confers risk for psychotic and affective disorders: a case control study (Q24816526) (← links)
- Specificity in the correlation of verbal memory and hippocampal neuron loss: dissociation of memory, language, and verbal intellectual ability (Q28240421) (← links)
- Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain (Q28266158) (← links)
- Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs (Q28296286) (← links)
- Analysis of TBX1 variation in patients with psychotic and affective disorders (Q30545900) (← links)
- BDNF Val66Met polymorphism and antipsychotic-induced tardive dyskinesia occurrence and severity: a meta-analysis (Q33566832) (← links)
- GWA study data mining and independent replication identify cardiomyopathy-associated 5 (CMYA5) as a risk gene for schizophrenia (Q33691275) (← links)
- Association of genetic variation in the MET proto-oncogene with schizophrenia and general cognitive ability (Q33766947) (← links)
- A schizophrenia risk gene, ZNF804A, is associated with brain white matter microstructure. (Q33768413) (← links)
- Cannabis use disorders in schizophrenia: effects on cognition and symptoms (Q33985743) (← links)
- Genome-wide mapping of IBD segments in an Ashkenazi PD cohort identifies associated haplotypes (Q33991709) (← links)
- DRD2 promoter region variation predicts antipsychotic-induced weight gain in first episode schizophrenia (Q34061159) (← links)
- A schizophrenia risk gene, ZNF804A, influences neuroanatomical and neurocognitive phenotypes (Q34128269) (← links)
- Sequencing an Ashkenazi reference panel supports population-targeted personal genomics and illuminates Jewish and European origins (Q34184913) (← links)
- Novel multi-nucleotide polymorphisms in the human genome characterized by whole genome and exome sequencing (Q34189262) (← links)
- Runs of homozygosity implicate autozygosity as a schizophrenia risk factor (Q34236675) (← links)
- Length distributions of identity by descent reveal fine-scale demographic history (Q34308519) (← links)
- The variance of identity-by-descent sharing in the Wright-Fisher model (Q34319577) (← links)
- Treatment of the schizophrenia prodrome: is it presently ethical? (Q34322842) (← links)
- Excess of homozygosity in the major histocompatibility complex in schizophrenia. (Q34379000) (← links)
- Genetic variation in DTNBP1 influences general cognitive ability (Q34484915) (← links)
- Cognitive and symptomatic predictors of functional disability in schizophrenia (Q34630528) (← links)
- Antipsychotic drugs and obesity (Q34648940) (← links)
- Empirical support for DSM-IV schizoaffective disorder: clinical and cognitive validators from a large patient sample (Q34758408) (← links)
- Antipsychotic treatment and functional connectivity of the striatum in first-episode schizophrenia (Q34861424) (← links)
- Brain morphometry using diffusion-weighted magnetic resonance imaging: application to schizophrenia (Q34975190) (← links)
- Genetic architecture of prostate cancer in the Ashkenazi Jewish population (Q35208177) (← links)
- DTNBP1 is associated with imaging phenotypes in schizophrenia (Q35223452) (← links)
- DTNBP1 genotype influences cognitive decline in schizophrenia (Q35688111) (← links)
- Targeting the schizophrenia genome: a fast track strategy from GWAS to clinic (Q35802177) (← links)
- Independent evidence for an association between general cognitive ability and a genetic locus for educational attainment (Q35845248) (← links)
- In vivo microRNA detection and quantitation in cerebrospinal fluid (Q35992237) (← links)
- Association of a Schizophrenia Risk Variant at the DRD2 Locus With Antipsychotic Treatment Response in First-Episode Psychosis (Q36148530) (← links)
- Relationship of Cognition to Clinical Response in First-Episode Schizophrenia Spectrum Disorders (Q36148536) (← links)
- A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes (Q36148557) (← links)
- Runs of homozygosity reveal highly penetrant recessive loci in schizophrenia. (Q36288960) (← links)
- Risk factors for psychosis: impaired social and role functioning (Q36386414) (← links)
- A Common Polymorphism in SCN2A Predicts General Cognitive Ability through Effects on PFC Physiology (Q36408315) (← links)
- Genome-wide autozygosity is associated with lower general cognitive ability (Q36717358) (← links)
- Expanded genetic screening panel for the Ashkenazi Jewish population. (Q36746589) (← links)
- Genetic variation in BDNF is associated with antipsychotic treatment resistance in patients with schizophrenia (Q36756159) (← links)
- Elucidating the relationship between DISC1, NDEL1 and NDE1 and the risk for schizophrenia: evidence of epistasis and competitive binding (Q36794017) (← links)
- Patterns of stress in schizophrenia (Q36796042) (← links)
- Baseline Striatal Functional Connectivity as a Predictor of Response to Antipsychotic Drug Treatment. (Q36838322) (← links)
- Early identification and high-risk strategies for bipolar disorder (Q36839819) (← links)
- Subgenual cingulate cortical activity predicts the efficacy of electroconvulsive therapy (Q36915400) (← links)
- Genomics and the future of pharmacotherapy in psychiatry (Q36951758) (← links)